The Academy of Pharmaceutical Physicians and Investigators (APPI), a nonprofit group of nearly 1,200 physician members involved in the clinical research enterprise, has joined the Clinical Trials Transformation Initiative (CTTI).
News
Advertisement
Phase Forward (NASDAQ: PFWD), a provider of data management solutions for clinical trials and drug safety, today announced a multi-year extension agreement with Eli Lilly and Company (NYSE: LLY).
Advertisement
Clinilabs, Inc., a specialty contract research organization (CRO), has completed expansion of its Phase I unit.
Covance Inc. (NYSE:CVD), a leading provider of drug development services, announced today that it signed a definitive agreement with Eli Lilly and Company (NYSE: LLY) to help transform Lilly's R&D model.
Dr. LingSing K. Chen has been chosen to head the new Translational Medicine department at QPS, a provider of research services for the pharmaceutical industry.
Abingdon Life Sciences, Inc. has entered into an agreement with Stason Pharmaceuticals, Inc to provide clinical and regulatory support for Stason?s drug development programs.
Advertisement
Medidata Solutions, a provider of clinical trial solutions, today announced that Taiho Pharmaceutical Co., Ltd. will implement Medidata Rave as its electronic data capture (EDC), management and reporting solution of choice.
Bilcare Global Clinical Supplies, a single-source provider of clinical trial services, announced that ithas opened its new global U.S. headquarters in San Francisco.
Clinilabs, Inc., a specialty contract research organization (CRO), is now a Mortara Certified Partner capable of collecting, processing, and transmitting annotated ECG data compliant with ECG Warehouse requirements.
CEO Chairman Jim Walker of Octagon Research Solutions, Inc., a provider of breakthrough software and services to the life sciences industry, today announced that Summit Drug Development Services, LLC has chosen both ViewPoint and StartingPoint to facilitate submission document authoring and integrated electronic regulatory submission management.
Advertisement
PAREXEL International Corporation (NASDAQ: PRXL), a global biopharmaceutical services organization, today provided an update with regard to the previously announced proposal whereby an indirect wholly owned subsidiary of PAREXEL will acquire the entire issued and to be issued ordinary share capital of ClinPhone plc, a company traded on the London Stock Exchange.
With the option to rent, the buy vs. build debate over software is kaput when it comes to major applications.
The story of two very different companies' transition to electronic.
Industry news focusing on the people and organizations who work in the clinical trials profession.
Highlights and insights from DIA's 44th Annual Meeting.
Industry news tidbits from around the world.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AbbVie and Genmab Secure FDA Approval for Epkinly Combination in Second-Line Plus Follicular Lymphoma
2
The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials
3
Managing Operational and Compliance Challenges on Emerging Platforms
4
Lessons from Successful Recruitment on Spotify, Nextdoor, and Threads
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
